Repaglinide/Rosiglitazone combination therapy of type 2 diabetes

被引：0
|
作者：
Raskin, P
McGill, J
Hale, P
Khutoryansky, N
Santiago, O
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A128 / A129
页数：2
相关论文
共 50 条
  • [21] Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus - A randomized controlled trial
    Fonseca, V
    Rosenstock, J
    Patwardhan, R
    Salzman, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1695 - 1702
  • [22] Rosiglitazone-metformin combination therapy improves glycemic control in Mexican patients with Type 2 diabetes
    Gomez-Perez, FJ
    Fanghanel-Salmon, G
    Berry, RA
    Warsi, G
    Gould, EM
    DIABETES, 2001, 50 : A436 - A436
  • [23] Repaglinide for type 2 diabetes mellitus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1027): : 55 - 58
  • [24] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycaemic control in patients with type 2 diabetes
    Ferreira, J. C. Arjona
    Dobs, A.
    Goldstein, B. J.
    Wieczorek, L.
    Golm, G.
    Davies, M. J.
    Williams-Herman, D.
    Kaufman, K. D.
    Amatruda, J. M.
    DIABETOLOGIA, 2008, 51 : S365 - S365
  • [25] Combination therapy for type 2 diabetes
    Bell, DSH
    AMERICAN FAMILY PHYSICIAN, 2001, 64 (11) : 1812 - +
  • [26] Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy
    Wang, Weiqing
    Bu, Ruifang
    Su, Qing
    Liu, Jianying
    Ning, Guang
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2791 - 2799
  • [27] Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus
    Kerenyi, Z
    Samer, H
    James, R
    Yan, Y
    Stewart, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 63 (03) : 213 - 223
  • [28] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Yilmaz, Hamiyet
    Gursoy, Alptekin
    Sahin, Mustafa
    Demirag, Nilgun Guvener
    ACTA DIABETOLOGICA, 2007, 44 (04) : 187 - 192
  • [29] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Hamiyet Yilmaz
    Alptekin Gursoy
    Mustafa Sahin
    Nilgun Guvener Demirag
    Acta Diabetologica, 2007, 44 : 187 - 192
  • [30] Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
    Hadi, Muhammad Abdul
    ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (01) : 2 - 2
12345